QTERN

Опис товару

About QTERN

QTERN is a prescription medicine supplied as film-coated tablets for oral administration. It is classified under combination antidiabetic agents used in the management of type 2 diabetes mellitus. The formulation combines two distinct active pharmaceutical ingredients designed to work through complementary mechanisms to help regulate blood glucose levels.

Key Benefits & Uses

• Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• Combines two active mechanisms into a single daily oral tablet for convenience.
• Helps manage blood glucose levels when single-agent therapy is insufficient.

Active Ingredient & Action

The active ingredients in QTERN are dapagliflozin propanediol and saxagliptin. Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor that works by reducing renal glucose reabsorption, leading to urinary glucose excretion. Saxagliptin is a dipeptidyl peptidase-4 inhibitor that works by inactivating incretin hormones, thereby increasing insulin synthesis and release and decreasing glucagon levels in a glucose-dependent manner.

Important Notes

QTERN is not suitable for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. Use of this medicine requires adherence to prescribed healthcare guidance regarding dosage, monitoring, and overall diabetes management plans.